CAS: 10130-89-9; 4-(Chlorosulfonyl)Benzoic Acid

相似化合物

69812-51-7 49584-26-1 85822-16-8

上下游产品

CAS号104-15-4 对甲苯磺酸 | CAS号98-59-9 对甲苯磺酰氯(PTSC) | CAS号150-13-0 对氨基苯甲酸 | CAS号5399-63-3 4-磺基苯甲酸单钾盐 | CAS号65-85-0 苯甲酸 | CAS号17405-00-4 4-carboxybenzen... | CAS号7790-94-5 氯磺酸 | CAS号636-78-2 4-磺基苯甲酸 | CAS号10252-68-3 4-[(异丁基氨基)磺酰基]苯甲酸 | CAS号4052-30-6 4-甲砜基苯甲酸 | CAS号57-66-9 丙磺舒 | CAS号402-55-1 4-(氟磺酰)苯酰氯 | CAS号17420-68-7 4-(氮杂环庚烷-1-磺酰基)-苯甲酸 | CAS号18738-58-4 4-(4-甲氧基苯磺酰基)-苯甲酸 | CAS号29171-72-0 4-二丙氨磺酰苄氧基氯 | CAS号69812-51-7 4-(氯磺酰基)苯甲酸甲酯 | CAS号13205-49-7 4-(乙硫基)苯甲酸 | CAS号100059-51-6 4-butylsulfonyl...

对甲苯磺酸置于氯磺酸,Potassium Permanganate,水,Potassium Hydroxide体系中,化学反应 6.0H,反应生成4-(氯磺酰)苯甲酸
参考文献:通过利用万古霉素/ D-Ala-D-Ala与铱金属配合物的相互作用获得人工亚胺还原酶的替代策略
标题:通过利用万古霉素/ D-Ala-D-Ala与铱金属配合物的相互作用获得人工亚胺还原酶的替代策略
摘要:基于万古霉素(van),一种抗生素糖肽和d-Ala-D-Ala(dada)二肽之间的超分子相互作用,合成并表征了一类新型的人工金属酶.在dada的n-末端存在铱(III)配体允许在环亚胺的不对称转移氢化中使用金属酶作为催化剂.特别地,如计算研究和催化结果所强调的,发现dada与金属螯合部分之间的连接类型是引起反应结果不对称的基础.在ph 5的0.1 M Ch 3 Coona缓冲液中使用[ircp *(m-I)cl] Cl⊂van配合物,可得到显着的70%(S)ee是通过还原奎尔定b而获得的.
Doi:10.1021/acs.Inorgchem.0C02969

专利信息

专利号:US-2009043069-A1
优先权日:2007-08-06
标 题 :Activated esters for synthesis of sulfonated telechelic polycarbonates
发明人：BRUNELLE DANIEL J; COLONNA MARTINO; FIORINI MAURIZIO; BERTI CORRADO; BINASSI ENRICO
权利人:GEN ELECTRIC
摘要:A process of making a sulfonated telechelic polycarbonate is described. A dihydroxy compound, a carbonate ester, and an activated ester of a sulfobenzoic acid salt are reacted together. The method results in a sulfonated telechelic polycarbonate which has a high percentage of sulfonated end groups, is soluble, and is transparent.

专利号:US-6943254-B2
优先权日:1997-03-07
标 题 :Synthesis of pyrazinyl pyridine-3-sulfonamide compounds
发明人：HOGAN PHILIP JOHN
权利人:ASTRAZENECA UK LTD
摘要:A process for the manufacture of: n n nwherein R is (1-4C)alkyl, carboxyl(1-4C)alkyl or 1,3,4-oxadiazol-2-yl comprises:n (a) reaction of the diazonium salt of 3-amino-2-chloropyridine with thionyl chloride in water and an electron transfer catalyst; (b) reaction with isobutyl-(3-methoxy-5-methylpyrazin-2-yl)carbamate and an alkali metal hydride in inert solvent; and (I) where R is (1-4C)alkyl, carboxy(1-4C)alkyl: (c) reaction with a boronic acid: n n (or an anhydride or ester therof) in the presence of a base and a palladium or nickel catalyst in solvent; and removal of the isobutoxy carbonyl group; or (ii) where R is 1,3,4-oxadiazol-2-yl (c) reaction with 4-methoxycarbonylphenylboronic acid (or an anhydride or ester thereof) with a source fluoride ion under aqueous conditions; (d) removal of the isobutoxycarbonyl protecting group; (e) conversion of the methyl ester group to the hydrazide; and (f) conversion to a 1,3,4-oxadiazol-2-yl moiety.

专利号:US-5939392-A
优先权日:1993-06-03
标 题 :Method of thrombin inhibition
发明人：ANTONSSON KARL THOMAS; BYLUND RUTH ELVY; GUSTAFSSON NILS DAVID; NILSSON NILS OLOV INGEMAR
权利人:ASTRA AB
摘要:The invention relates to new competitive tripeptide inhibitors of trypsin-like serine proteases, their synthesis, pharmaceutical compositions containing the compounds as active ingredients, and the use of the compounds as thrombin inhibitors, anticoagulants and antiinflammatory inhibitors for prophylaxis and treatment of related diseases.

专利号:US-7371852-B2
优先权日:2003-01-22
标 题 :Alkyl-linked nucleotide compositions
发明人：HARDEMAN KLASS P; HALL STEVEN E; WARE ROY W; HINKLEY LINDSAY A; JENKS MATTHEW G
权利人:SERENEX INC
摘要:Alkyl-linked nucleotide non-homogeneous solid supports and nucleotide affinity media comprising an alkyl-linked nucleotide are provided. The linker is generally a hydrophobic linker that can be a 3, 4, 5, 6, 7, 8, 9, 10, or a longer carbon chain. Also included in the invention are methods for synthesis of an alkyl-linked nucleotide, nucleotide affinity media and methods of use thereof for affinity chromatography and screening methods.

专利号:CN-101365674-A
优先权日:2005-07-21
标题:Modulators of interleukin-1 and tumor necrosis factor alpha, synthesis of the modulators and methods of using the modulators

专利号:US-5723444-A
优先权日:1993-06-03
标 题:Starting materials in the synthesis of thrombin and kinogenase inhibitors